Treasury Board of Canada Secretariat
Symbol of the Government of Canada

ARCHIVED - Health Canada


Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

Table 7: Upcoming Evaluations (Next three fiscal years)


Fiscal Year 2009 - 2010
Name of Evaluation Program Type Status Expected Completion Date
Implementation of a Patient Wait Times Guarantee Pilot Project Fund Summative Evaluation
(Grants & Contributions) (G&Cs)
Ongoing March 2010
Augmenting Health Canada’s Response to Bovine Spongiform Encephalopathy (BSE) - RSE 1, Phase II of Health Canada’s and the Public Health Agency of Canada’s response to BSE in the Areas of Risk Assessment and Targeted Research = BSE II Summative Evaluation Planned March 2010
Natural Health Products Strategic Evaluation Ongoing September 2009
Food Safety and Nutrition Quality Strategic Evaluation Ongoing October 2009
Medical Devices Strategic Evaluation Ongoing March 2010
Climate and Infectious Disease Alert and Response Systems to Protect the Health of Canadians Program Evaluation Planned March 2010
Air Quality Health Index and Forecast Program Program Evaluation Planned March 2010
Canada’s Clear Air Agenda - Clean Air Regulatory Agenda
(Environment Canada Lead)
Thematic Evaluation Planned March 2010
Federal Contaminated Sites Action Plan Summative Evaluation Planned March 2010
National Anti-Drug Strategy
(Justice Canada Lead)
Horizontal Formative Evaluation
(including G&Cs)
Planned March 2010
Building Public Confidence in Pesticide Regulation and Improving Access to Pest Management Products Summative Evaluation Ongoing March 2010
Children and Youth (Cluster) Strategic Evaluation
(including G&Cs)
Ongoing September 2009
Communicable Disease Control (Cluster) Strategic Evaluation
(including G&Cs)
Ongoing October 2009
Continued Implementation of the Labrador Innu Comprehensive Healing Strategy Summative Evaluation Ongoing March 2010
Chronic Disease and Injury Prevention (Cluster) Strategic Evaluation
(including G&Cs)
Planned March 2010
Environmental Health Research (Cluster) Strategic Evaluation
(including G&Cs)
Planned March 2010
Non-Insured Health Benefits (Cluster) Strategic Evaluation
(including G&Cs)
Ongoing March 2010
Health Facilities and Capital Program Strategic Evaluation
(including G&Cs)
Planned March 2010


Fiscal Year 2010 - 2011
Name of Evaluation Program Type Status Expected Completion Date
Veterinary Drugs Strategic Evaluation Planned March 2011
Nutrition Promotion Strategic Evaluation Planned March 2011
Canada’s Clean Air Agenda - Adaptation Theme
(Environment Canada Lead)
Thematic Evaluation Planned March 2011
Canada’s Clear Air Agenda - Indoor Air Quality Theme Thematic Evaluation Planned March 2011
Protecting Canadians and the Environment from Toxic Substances through a Chemical Management Plan Summative Evaluation Planned March 2011
Federal Tobacco Control Strategy Summative Evaluation Planned March 2011
Mental Health and Addictions (Cluster) Strategic Evaluation
(including G&Cs)
Planned March 2011
Environmental Health and Research (Cluster) Strategic Evaluation
(including G&Cs)
Planned March 2011


Fiscal Year 2011 - 2012
Name of Evaluation Program Type Status Expected Completion Date
Health Care Policy Contribution Program Summative Evaluation
(Contribution)
Planned March 2012
Biologics Strategic Evaluation Planned March 2012
Organ and Tissue Donation and Transplantation Program Summative Evaluation
(G&Cs)
Planned March 2012
Horizontal Evaluation of the Genomics Research and Development Initiative Summative Evaluation Planned March 2012
Environmental Health Guide Program Evaluation Planned March 2012
Strengthening and Modernizing Canada’s Safety System for Health, Consumer and Food Products - Consumer Products Component Evaluation Planned March 2012
Drug Treatment Funding Program of the National Anti-Drug Strategy Summative Evaluation
(G&Cs)
Planned March 2012
National Anti-Drug Strategy
(Justice Canada Lead)
Horizontal Summative Evaluation
(including G&Cs)
Planned March 2012
Strengthening and Modernizing Canada’s Safety System for Health, Consumer and Food Products - Pesticide Products Component Evaluation Planned March 2012
Primary Care (Cluster) Strategic Evaluation
(including G&Cs)
Planned March 2012
Transfer (Health Governance and Infrastructure Support) (Cluster) Strategic Evaluation
(Transfer Payment)
Planned March 2012

Evaluation plan